Hopscotch technique: A novel method for percutaneous closure of paravalvular leaks

Ruiz, Carlos E.; Li, Chi-Hion; Jelnin, Vladimir; Perk, Gila; Wp, Dillon; Kronzon, Itzhak; Chad, Kliger

doi:10.1002/ccd.26854

Cited by 3 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Failure to reduce mitral PVL in 1 (5%) patient occurred due to the tortuous anatomy of the defect (crescent shape with surgical suture material crossing it in the middle). Retrospectively analyzing the periprocedural events of these particular patients, it could have been helpful to attempt to implant two small square occluders in the Hopscotch technique fashion [ 30 ].…”

Section: Discussionmentioning

confidence: 99%

Retrospective analysis of single-center early and midterm results of transapical catheter‑based mitral paravalvular leak closure with a purpose-specific device

Zorinas¹,

Janušauskas²,

Davidavičius³

et al. 2018

pwki

View full text Add to dashboard Cite

IntroductionDue to the recent lack of definitions to establish the severity of paravalvular leak (PVL) and endpoints for its treatment, the effectiveness and safety of a new device for PVL closure have not been comprehensively analyzed.AimTo analyze a single center’s experience of mitral PVL closure in a surgical transapical catheter-based fashion with a purpose-specific device.Material and methodsThis is a retrospective cohort study of patients following transapical catheter-based mitral PVL closure with a purpose-specific device. Data were analyzed at baseline, perioperatively, at discharge, at six months and annually after the procedure.ResultsNineteen patients underwent surgical transapical catheter-based mitral PVL closure with the Occlutech PLD Occluder. Mean follow-up time was 20 ±7 (range: 9–33) months. The patients’ mean age was 64 ±7 years, and 11 (58%) were male. Technical, device and individual patient success at follow-up was achieved in 18 (95%), 16 (84%) and 16 (84%) patients respectively. Median intensive therapy unit stay was one day (1–4) and mean hospital stay was 11 ±4 days. A reduction of paravalvular regurgitation to a mild or lesser degree was achieved in 18 (95%) patients. There were no strokes or myocardial infarctions at follow-up. There were no deaths at 30 days after the procedure. One (5%) patient expired due to progression of heart failure 12 months after surgery. None of the patients required immediate conversion to full sternotomy.ConclusionsSurgical transapical catheter-based mitral PVL closure with the Occlutech PLD Occluder is a safe and clinically effective treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Retrospective analysis of single-center early and midterm results of transapical catheter‑based mitral paravalvular leak closure with a purpose-specific device

Zorinas¹,

Janušauskas²,

Davidavičius³

et al. 2018

pwki

View full text Add to dashboard Cite

show abstract

“…Once the device is deployed, an immediate assessment of mechanical leaflet mobility is performed, followed by a search for residual leaks, frequently under hemodynamic stress (volume challenge and pharmacological manipulation of the arterial pressure). While PVL closure traditionally relies on a transseptal approach, a transapical "Hopscotch" approach has been described recently, which also benefits from echocardiographic intraprocedural guidance in combination with CT angiography (37).…”

Section: (V) the Paravalvular Leak Academic Researchmentioning

confidence: 99%

Role of imaging in novel mitral technologies—echocardiography and computed tomography

Loghin¹,

Loghin²

2018

Ann. Cardiothorac. Surg.

View full text Add to dashboard Cite

As minimally invasive cardiovascular procedures gain popularity, novel transcatheter mitral valve repair devices continue to emerge. The success of these technologies is critically dependent on high quality imaging performed at all stages: patient selection, intervention planning, intraprocedural guidance, monitoring complications and follow-up. We present an overview of specific imaging requirements and challenges applicable to mitral valve interventional techniques. Modern valve imaging is multimodal and primarily combines echocardiography and computed tomography (CT). Echocardiography remains the gold standard for detailed anatomic imaging, complete hemodynamic characterization and real-time guidance and evaluation of procedural success. CT is indispensable for mitral annulus (MA) imaging and in predicting left ventricular outflow tract (LVOT) obstruction post transcutaneous mitral valve replacement (TMVR). 3D modeling, fusion imaging and automated image analysis may further contribute to the evolutionary transformation of valvular heart imaging.

show abstract

Transcatheter Closure of Mitral Paravalvular Leak

Pasala¹,

Jelnin²,

Ruiz³

2021

Transcatheter Mitral Valve Therapies

View full text Add to dashboard Cite

Hopscotch technique: A novel method for percutaneous closure of paravalvular leaks

Abstract: The Hopscotch technique is feasible and safety for patients with mitral paravalvular leak when boundaries prevent full device expansion. © 2017 Wiley Periodicals, Inc.

Cited by 3 publications

References 16 publications

Retrospective analysis of single-center early and midterm results of transapical catheter‑based mitral paravalvular leak closure with a purpose-specific device

Retrospective analysis of single-center early and midterm results of transapical catheter‑based mitral paravalvular leak closure with a purpose-specific device

Role of imaging in novel mitral technologies—echocardiography and computed tomography

Transcatheter Closure of Mitral Paravalvular Leak

Contact Info

Product

Resources

About